Medicine and Dentistry
Brain Ischemia
100%
Clinical Study
100%
Glucagon Like Peptide 1
100%
Glucagon-Like Peptide-1 Agonist
100%
Systematic Review
100%
Neuroprotective Agent
100%
Apoplexy
83%
Dipeptidyl Peptidase-4 Inhibitor
83%
Programmed Cell Death
33%
Diabetes Mellitus
33%
Oxidative Stress
33%
Infarction
33%
Glucagon Like Peptide 1 Receptor
16%
Prophylaxis
16%
Maturity Onset Diabetes of the Young
16%
Brain Blood Flow
16%
Experimental Stroke
16%
Neuroprotection
16%
Clinical Trial
16%
Ischemia
16%
Diabetes
16%
Serositis
16%
Combination Therapy
16%
Keyphrases
Glucagon-like
100%
Ischemic Stroke
100%
Neuroprotective Mechanisms
100%
GLP-1 Receptor Agonist
71%
Dipeptidyl peptidase-4 (DPP-4)
71%
Glucagon-like peptide-1 Receptor (GLP-1R)
28%
A1 Receptor
28%
Infarct Volume
28%
Apoptosis
28%
Diabetic
14%
Embase
14%
Cochrane Library
14%
Inflammation Oxidative Stress
14%
Cerebral Blood Flow
14%
Promising Treatment
14%
Acute Treatment
14%
Literature Search
14%
Neurotoxicity
14%
Stroke Risk
14%
Receptor Agonist
14%
Acute Inflammatory Response
14%
Clinical Trials
14%
MEDLINE
14%
Type 2 Diabetes Prevention
14%
Mediating Effect
14%
Ischemia
14%
Diabetic Animals
14%
Experimental Stroke
14%
Prophylactic Treatment
14%
Oxidative Stress
14%
Mechanism of Action
14%
Without Diabetes
14%
Therapeutic Efficacy
14%
Neuroprotection
14%
Neuroprotective Effect
14%
Ischemic Brain Damage
14%
Patients with Diabetes
14%
Functional Outcome
14%
Non-diabetic
14%
Inflammation
14%
Patients at Risk
14%
Stroke Patients
14%
Endothelial Leakiness
14%
Pharmacology, Toxicology and Pharmaceutical Science
Preclinical Study
100%
Brain Ischemia
100%
Glucagon Like Peptide 1 Receptor Agonist
100%
Neuroprotective Agent
100%
Glucagon-Like Peptide-1
100%
Cerebrovascular Accident
83%
Dipeptidyl Peptidase IV Inhibitor
83%
Inflammation
50%
Infarction
33%
Diabetes Mellitus
33%
Ischemia
16%
Neuroprotection
16%
Combination Therapy
16%
Glucagon-Like Peptide 1 Receptor
16%
Non Insulin Dependent Diabetes Mellitus
16%
Clinical Trial
16%
Experimental Stroke
16%
Excitotoxicity
16%
Neuroscience
Cerebrovascular Accident
100%
Glucagon-Like Peptide-1 Agonist
100%
Brain Ischemia
100%
Glucagon-Like Peptide-1
100%
Neuroprotective Agent
100%
Dipeptidyl Peptidase-4 Inhibitor
83%
Diabetes Mellitus
33%
Programmed Cell Death
33%
Oxidative Stress
33%
Ischemia
16%
Brain Injury
16%
Glucagon-Like Peptide 1 Receptor
16%
Excitotoxicity
16%
Neuroprotection
16%
Biochemistry, Genetics and Molecular Biology
Glucagon-Like Peptide 1 Receptor
100%
Preclinical Study
100%
Glucagon-Like Peptide-1
100%
Receptor Agonists
85%
Dipeptidyl Peptidase-4
71%
Programmed Cell Death
28%
Oxidative Stress
28%
Infarct Volume
28%
Cochrane Library
14%
Excitotoxicity
14%
Clinical Trial
14%
Brain Blood Flow
14%
Immunology and Microbiology
Glucagon-Like Peptide-1
100%
Preclinical Study
100%
Agonist
85%
Dipeptidyl Peptidase IV
71%
Infarct Volume
28%
Programmed Cell Death
28%
Oxidative Stress
28%
Brain Blood Flow
14%
Inflammation Response
14%
Cochrane Library
14%